DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Xerox Corporation To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Xerox Corporation (NYSE: XRX) ("Xerox" or the "Company") common stock during the period between April 23, 2012 and October 23, 2015, inclusive (the "Class Period"). Investors who wish to become proactively involved in the litigation have until December 23, 2016 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Xerox common stock during the Class Period. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants' failure to disclose during the Class Period that the Company's existing Health Enterprise projects were experiencing major delays and cost overruns and it would be unable to deliver Health Enterprise implementations at sustainable profits.

According to the complaint, following October 22, 2014 and April 24, 2015 press releases announcing disappointing margins due to high expense levels incurred on the protracted implementation of the Health Enterprise projects, an October 23, 2015 press release announcing that the Company would be recording a $385 million pre-tax charge related to assets and unrecoverable costs associated with its Health Enterprise implementation projects and that it would not complete its projects in California and Montana, and an October 26, 2015 release of financial results that missed estimates due in part to lost revenues from the termination of the projects, the value of Xerox shares declined significantly.

If you liked this article you might like

Someone Has Been Buying Xerox Aggressively

The Truth Behind Middle America's Resentment of Cosmopolitan 'Elites'

The Retail Apocalypse Is About to Descend on Wall Street This Coming Week